SummaryDoing due diligence on a small portion of the mosaic theory related to Inovio and other biotechs led me to doing a small initial study on RedChip.
While RedChip has Inovio listed prominently in multiple areas on its website and has recently Tweeted about it, Inovio is not a client and has never paid RedChip.
Biotech and healthcare stocks listed as RedChip […]
NASDAQ leads -up 0.6% to 4787
The October correction of ~7% was a “headfake” as macro events scared many investor away
Technology and Healthcare Stocks Lead The Way
The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD.
Biotech stocks are at new highs with all major ETFs rallying in November. Our top ETF pick FBT is […]
View gallery.Until the markets pullback a bit, investors and traders will ride this gravy train as long as it goes. Thanks to the market run-up a lot of stocks already seem somewhat extended. However, there are some stocks that are a little late to the party and are just now breaking higher.For example, Celldex Therapeutics, Inc. (NASDAQ: CLDX) just recently broke […]
From DailyWealthHow to Make Money in Biotech Stocks, No M.D. RequiredBy Dr. Steve SjuggerudTuesday, November 25, 2014″If you catch just one biotech bull market in your lifetime, you may never have to work again…”I’ve written that many times in our research. Why? Because biotech booms are like nothing else in American investing…The potential gains – without leverage – are extraordinary. […]
View gallery.Last week’s market price action was somewhat like watching paint peel. In other words, there just wasn’t much going on.Even though the market edged higher for the fourth straight week and the S&P 500 hit new record highs, the gains came during the smallest market moves since 1979.After Monday, the benchmark S&P rose or fell less than 0.1 percent […]
View gallery.With the help of an almost vertical rise in the overall stock market, most industries within the market have also performed very well. As they say, “a rising tide raises all ships.”Some industries, however, have performed better than others. For example, airlines and railroads have been the two top-performing industries, while gold miners have been the worst.Another industry that’s […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
That bright neon sign you’re looking at are biotech stocks flashing, “Buy me!”So put down your morning joe. Go ahead, do it. And ignore all incoming e-mail for the next few minutes. Because the biotech breakout has arrived — and it can make you a bundle over the next few months.That’s right. Forget about this month’s stock roller-coaster ride. Yeah, sure, it […]
In last week’s Benzinga article on InterMune (NASDAQ: ITMN), some of the warning signs for the overall stock market were highlighted.Those warnings became more than just warnings last week, as the market took some significant hits. Last Thursday’s 300-plus drop on the Dow Jones Industrial Average was the main headline.Since then the market has continued to decline, but some stocks […]
Sometimes an “up” day isn’t just any “up” day.
Not only did the stock market push higher yesterday, the S&P made a very specific, positive move in the form of a break through its 3-year channel resistance. This should lead to an increase in prices for the S&P, at least in the short-run.
Well, thanks to the market’s move higher, several stocks […]
